Knowledge Transfers in the US Biopharmaceutical Market During a Time of Transition
Tóm tắt
The purpose of the paper is to examine the effects that firm factors, multinational corporations, and location have on explicit and tacit knowledge transfers originating in US biopharmaceutical firms during a time of transition. Examination of all known biopharmaceutical formal tacit and explicit knowledge transfers was done. The study performs logistic regression to test its hypotheses. The study identifies tacit knowledge transfers with full or partial equity acquisitions in firms. Explicit knowledge transfers are associated with licensing agreements or product and technology acquisitions. The study finds biotechnology firms and private firms are more likely to transfer tacit knowledge than explicit knowledge. Multinational firms are more likely to acquire tacit knowledge than explicit knowledge. Local transfers (compared with non-local or foreign transfers) are more likely to be tacit knowledge transfers. Firms within clusters are also more likely to transfer explicit knowledge than tacit knowledge. Given the choice between tacit and explicit knowledge transfers, firms prefer tacit knowledge transfers.
Tài liệu tham khảo
Grant RM. Toward a knowledge-based theory of the firm. Strateg Manag J. 1996;17(S2):109–22.
Berry H. Global integration and innovation: multicountry knowledge generation within MNCs. Strateg Manag J. 2014;35(6):869–90.
Kogut B, Zander U. Knowledge of the firm and the evolutionary theory of the multinational corporation. J Int Bus Stud. 1993;24(4):625–45.
Felin T, Hesterly WS. The knowledge-based view, nested heterogeneity, and new value creation: philosophical considerations on the locus of knowledge. Acad Manag Rev. 2007;32(1):195–218.
Albino V, Garavelli AC, Schiuma G. Knowledge transfer and inter-firm relationships in industrial districts: the role of the leader firm. Technovation. 1998;19(1):53–63.
Arend RJ, Patel PC, Park HD. Explaining post-IPO venture performance through a knowledge-based view typology. Strateg Manag J. 2014;35(3):376–97.
Nonaka I. A dynamic theory of organizational knowledge creation. Organ Sci. 1994;5(1):14–37.
DeCarolis DM, Deeds DL. The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry. Strateg Manag J. 1999;20(10):953–68.
Van Wijk R, Jansen JJ, Lyles MA. Inter-and intra-organizational knowledge transfer: a meta-analytic review and assessment of its antecedents and consequences. J Manag Stud. 2008;45(4):830–53.
Teigland R, Wasko M. Knowledge transfer in MNCs: examining how intrinsic motivations and knowledge sourcing impact individual centrality and performance. J Int Manag. 2009;15(1):15–31.
Kostova T. Transnational transfer of strategic organizational practices: a contextual perspective. Acad Manag Rev. 1999;24:306–24.
Inkpen AC, Tsang EW. Social capital, networks, and knowledge transfer. Acad Manag Rev. 2005;30(1):146–65.
Girard J, Girard J. Defining knowledge management: toward an applied compendium. OJAKM. 2015;3(1):20.
Carayannis EG. Fostering synergies between information technology and managerial and organizational cognition: the role of knowledge management. Technovation. 1999;19(4):219–31.
Biggerio L. The location of multinationals in industrial districts: knowledge transfer in biomedicals. J Technol Transfer. 2002;27:111–22.
Park C, Vertinsky I, Becerra M. Transfers of tacit vs. explicit knowledge and performance in international joint ventures: the role of age. Int Bus Rev. 2015;24:89–101.
Polanyi M. Tacit knowing: its bearing on some problems of philosophy. Rev Mod Phys. 1962;34(4):601–16.
Blome C, Schoenherr T, Eckstein D. The impact of knowledge transfer and complexity on supply chain flexibility: a knowledge-based view. Int J Prod Econ. 2014;147:307–16.
Leal-Rodríguez A, Leal-Millán A, Roldán-Salgueiro JL, Ortega-Gutiérrez J. Knowledge management and the effectiveness of innovation outcomes: the role of cultural barriers. Electron J Knowl Manag. 2013;11(1):62–71.
Howells J. The geography of knowledge: never so close but never so far apart. J Econ Geogr. 2012;12:1003–20.
Ranft AL, Lord MD. Acquiring new knowledge: the role of retaining human capital in acquisitions of high-tech firms. J High Technol Manag Res. 2000;11(2):295–319.
Hedlund G. A model of knowledge management and the N-form corporation. Strateg Manag J. 1994;15(S2):73–90.
Quintas P, Lefrere P, Jones G. Knowledge management: a strategic agenda. Long Range Plan. 1997;30(3):385–91.
Hall LA, Bagchi-Sen S. An analysis of firm-level innovation strategies in the US biotechnology industry. Technovation. 2007;27(1):4–14.
Minbaeva DB. Knowledge transfer in multinational corporations. Manag Int Rev. 2007;47(4):567–93.
Pekár P, Margulis MS. Equity alliances take centre stage. Bus Strateg Rev. 2003;14(2):50–62.
Bell GG, Zaheer A. Geography, networks, and knowledge flow. Organ Sci. 2007;18(6):955–72.
Eisingerich AB, Bell SJ, Tracey P. How can clusters sustain performance? The role of network strength, network openness, and environmental uncertainty. Res Policy. 2010;39:239–53.
Chiaroni D, Chiesa V. Forms of creation of industrial clusters in biotechnology. Technovation. 2006;26(9):1064–76.
Xia T, Roper S. From capability to connectivity—absorptive capacity and exploratory alliances in biopharmaceutical firms: a US–Europe comparison. Technovation. 2008;28(11):776–85.
Malerba F, Orsenigo L. Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history-friendly model. Ind Corp Chang. 2002;11(4):667–703.
Gupta AK, Govindarajan V. Knowledge flows within multinational corporations. Strateg Manag J. 2000;21(4):473–96.
Wernerfelt B. A resource-based view of the firm. Strateg Manag J. 1984;5(2):171–80.
Barney J. Firm resources and sustained competitive advantage. J Manag. 1991;17(1):99–120.
Peteraf MA. The cornerstones of competitive advantage: a resource-based view. Strateg Manag J. 1993;14(3):179–91.
Hall R, Andriani P. Managing knowledge associated with innovation. J Bus Res. 2003;56(2):145–52.
Theriou NG, Aggelidis V, Theriou G. A theoretical framework contrasting the resource-based perspective and the knowledge-based view. Eur Res Stud. 2009;12(3):177.
Kaplan S, Schenkel A, von Krogh G, Weber C. Knowledge-based theories of the firm in strategic management: a review and extension. Int J Proj Manag. 2001;25:1–47.
Schweizer L. Organizational integration of acquired biotechnology companies into pharmaceutical companies: the need for a hybrid approach. Acad Manag J. 2005;48(6):1051–74.
Galambos L, Sturchio JL. Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation. Bus Hist Rev. 1998;72(2):250–78.
Powell W, Brantley P. Competitive cooperation in biotechnology: learning through networks? In: Nohria N, Eccles R, editors. Networks and organizations. Boston: Harvard Business School Press; 1992. p. 366–94.
Natalicchio A, Petruzzelli AM, Garavelli AC. A literature review on markets for ideas: emerging characteristics and unanswered questions. Technovation. 2014;34(2):65–76.
Lerner J, Merges RP. The control of technology alliances: an empirical analysis of the biotechnology industry. J Ind Econ. 1998;46(2):125–56.
Williams DR, Young CC, Coffey BS. Acquisitions in the biopharma-ceutical IPO market: collaboration, competition and co-opetition. Manag Decis Econ. 2017;38(8):1162–71.
Grant RM, Baden-Fuller C. A knowledge accessing theory of strategic alliances. J Manag Stud. 2004;41(1):61–84.
Rothaermel FT, Deeds DL. Exploration and exploitation alliances in biotechnology: a system of new product development. Strateg Manag J. 2004;25(3):201–21.
Mowery DC, Oxley JE, Silverman BS. Strategic alliances and interfirm knowledge transfer. Strateg Manag J. 1996;17(S2):77–91.
Ferreira MP, Santos JC, de Almeida MIR, Reis NR. Mergers & Acquisitions Research: a bibliometric study of top strategy and International Business Journals, 1980–2010. J Bus Res. 2014;67(12):2550–8.
Lodh S, Battaggion MR. Technological breadth and depth of knowledge in innovation: the role of mergers and acquisitions in biotech. Ind Corp Chang. 2014;24(2):383–415.
Pisano G. The development factory. Boston, MA: Harvard Business School Press; 1997.
Feldman MP, Ronzio CR. Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing. Entrep Reg Dev. 2001;13(1):1–16.
Lim PL, Garnsey E, Gregory M. Product and process innovation in biopharmaceuticals: a new perspective on development. R&D Manag. 2006;36(1):27–36.
Carlson PE. Biotechnology industry trends. 2006. http://www.regionalgrowth.com/ pubs/industry-studies/Biotech_Industry_Trends.pdf.
Cockburn IM. The changing structure of the pharmaceutical industry. Health Aff. 2004;23(1):10–22.
DiMasi JA, Grabowski HG. The cost of biopharmaceutical R&D: is biotech different? Manag Decis Econ. 2007;28(4–5):469–79.
Ernst & Young. Beyond Borders: global biotechnology report 2009. 2009. http://www.ey.com/Publication/ vwLUAssets/Global_ biotechnology_report_2009./$FILE/ Beyond_borders_2009.pdf. Accessed 20 March 2017.
Williams DR, Young CC. Trends in biopharmaceutical IPOS: 1996-2005. J Health Care Finance. 2005;33(2):39–54.
Kogut B, Zander U. Knowledge of the firm, combinative capabilities, and the replication of technology. Organ Sci. 1992;3(3):383–97.
Eden L, Levitas E, Martinez RJ. The production, transfer and spillover of technology: comparing large and small multinationals as technology producers. Small Bus Econ. 1997;9(1):53–66.
Reus TH, Lamont BT, Ellis KM. A darker side of knowledge transfer following international acquisitions. Strateg Manag J. 2016;37(5):932–44.
Kramer JP, Marinelli E, Iammarino S, Diez JR. Intangible assets as drivers of innovation: empirical evidence on multinational enterprises in German and UK regional systems of innovation. Technovation. 2011;31(9):447–58.
Hill CW, Hwang P, Kim WC. An eclectic theory of the choice of international entry mode. Strateg Manag J. 1990;11(2):117–28.
Martin X, Salomon R. Knowledge transfer capacity and its implications for the theory of the multinational corporation. J Int Bus Stud. 2003;34(4):356–73.
Reilly M, Scott PS. Subsidiary driven innovation within shifting MNC structures: identifying new challenges and research directions. Technovation. 2014;34(3):190–202.
Kale P, Singh H. Managing strategic alliances: what do we know now, and where do we go from here? Acad Manag Perspect. 2009;23(3):45–62.
Shan W, Song J. Foreign direct investment and the sourcing of technological advantage: evidence from the biotechnology industry. J Int Bus Stud. 1997;28(2):267–84.
Almeida P, Phene A. Subsidiaries and knowledge creation: the influence of the MNC and host country on innovation. Strateg Manag J. 2004;25(8–9):847–64.
Waxell A, Malmberg A. What is global and what is local in knowledge-generating interaction? The case of the biotech cluster in Uppsala, Sweden. Entrep Reg Dev. 2007;19(2):137–59.
Phene A, Fladmoe-Lindquist K, Marsh L. Breakthrough innovations in the US biotechnology industry: the effects of technological space and geographic origin. Strateg Manag J. 2006;27(4):369–88.
Bagchi-Sen S. Strategic considerations for innovation and commercialization in the US biotechnology sector. Eur Plan Stud. 2007;15(6):753–66.
Kenney M. Biotechnology and the creation of a new economic space. Private Science: Biotechnology and the Rise of the Molecular Sciences, 1998;131–143.
Powell WW, Koput KW, Bowie JI, Smith-Doerr L. The spatial clustering of science and capital: accounting for biotech firm-venture capital relationships. Reg Stud. 2002;36(3):291–306.
Liang H, Zhang Z. The effects of industry characteristics on the sources of technological product and process innovation. J Technol Transf. 2012;37(6):867–88.
Breschi S, Lissoni F. Mobility of skilled workers and co-invention networks: an anatomy of localized knowledge flows. J Econ Geogr. 2009;9(4):439–68.
Gray N. Untying the Gordian knot, PharmExec. 2005;84–100.
Teece DJ, Pisano G, Shuen A. Dynamic capabilities and strategic management. Strateg Manag J. 1997;18(7):509–33.
Berndt ER, Mortimer R, Bhattacharjya A, Parece A, Tuttle E. Authorized generic drugs, price competition, and consumers’ welfare. Health Aff. 2007;26(3):790–9.